Protagenic Therapeutics, Inc.\new (PTIX): Shareholders' Equity
$2.62M
As of 2026-03-31
$1.72M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $2.62M | n/m | 2026-08-14, Balance as of period end |
| 2025-03-31 | -$4.95M | n/a | 2026-08-14, Balance as of period end |
| 2024-12-31 | $1.01M | -72.4% | 2025-03-31, Balance as of period end |
| 2023-12-31 | $3.67M | -47.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $6.92M | -30.4% | 2024-05-14, Balance as of period end |
| 2021-12-31 | $9.94M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | -$1.15M | n/m | 2022-04-07, Balance as of period end |
| 2019-12-31 | -$634.4K | n/m | 2021-03-25, Balance as of period end |
| 2018-12-31 | -$210.9K | n/m | 2020-04-29, Balance as of period end |
| 2017-12-31 | $1.22M | -50.8% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $2.48M | n/m | 2018-04-02, Balance as of period end |
| 2015-12-31 | -$667.2K | n/a | 2017-05-08, Balance as of period end |
| 2015-06-30 | -$497.0K | n/m | 2015-09-25, Balance as of period end |
| 2014-06-30 | -$21.0K | n/a | 2015-09-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $2.62M | n/m |
| Bio-Path Holdings, Inc. (BPTH) | 2024-12-31 | $154.0K | -65.1% |
| Pulmatrix, Inc. (PULM) | 2025-12-31 | $3.81M | -57.4% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $2.99M | -62.8% |
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | $2.74M | -63.2% |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | $2.67M | n/m |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $1.08M | -92.0% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.15M | +4.4% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.83M | -34.5% |
Compare PTIX, BPTH, PULM, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗